A	B	C	D	E	F	G	H	I	J	K	L	M
1
2		Brand	Generic	Indication	MOA	Approved	IP	Economics	Admin		Price	184.94
3		Spikevax		COVID-19							Shares	384.180469	Q322
4						Phase					MC	71050.33593686
5		mRNA-1345		RSV		III					Cash	17003	Q322
6		mRNA-1647		CMV		III					Debt	0	Q322
7		mRNA-1010		Influenza							EV	54047.33593686001
8		mRNA-1020		Influenza
9		mRNA-1030		Influenza
10		mRNA-1011		Influenza
11		mRNA-1012		Influenza							CEO: Stephane Bancel
12		mRNA-3927		Propionic Acidemia							CFO: James Mock
13		mRNA-3745		GSD1a							CCO: Arpa Garay
14		mRNA-3705		MMA
15		mRNA-3139		OTC
16		mRNA-1893		Zika
17		mRNA-1215		Nipah	Vaccine
18		mRNA-4157/V940		Oncology	PCV	II		MRK
19		mRNA-1608		HSV
20		mRNA-1574		HIV	Vaccine	I
21		mRNA-1468		VZV
22		mRNA-1189		EBV	Vaccine	I
23		VXc-522		Cystic Fibrosis				VRTX
24		mRNA-3283		PKU
25
26						12/13/22: 4157 Phase II data
27						Q123: RSV data
28						Q123: influenza p3 immunogenicity data